Clinical Trial Update: Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing a Phase 1/Phase 2 study evaluating the effectiveness and safety of mesenchymal stem cell therapy in patients with Long COVID/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute COVID-19 Syndrome

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Changhai Hospital | Conditions: Long COVID, Post-Acute COVID-19 Syndrome | Phase 1, Phase 2 | Status: RECRUITING